| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |